Showing results (71-80 of 406) with videos related to

Sort By:
Pageof 41
Psychopharmacology|August 6, 1999
Pindolol binding to 5-HT1A receptors in the human brain confirmed with positron emission tomographyB Andrée, S O Thorberg, C Halldin, et al.
Psychiatry Research|August 8, 1995
No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperoneA L Nordström, L Farde, L Eriksson, et al.
Psychopharmacology|January 1, 1988
Remoxipride--a new potential antipsychotic drug. Pharmacological effects and pharmacokinetics following repeated oral administration in male volunteersL Farde, M Grind, M I Nilsson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 1998
PET imaging of central 5-HT2A receptors with carbon-11-MDL 100,907H Ito, S Nyberg, C Halldin, et al.
Annals of Nuclear Medicine|February 1, 1996
Effects of cocaine on [11C]norepinephrine and [11C] beta-CIT uptake in the primate peripheral organs measured by PETT Suhara, L Farde, C Halldin, et al.
Neuroscience|January 30, 2010
Age-related reduction in dopamine D1 receptors in the human brain: from late childhood to adulthood, a positron emission tomography studyA Jucaite, H Forssberg, P Karlsson, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 4, 2000
PET-Determination of robalzotan (NAD-299) induced 5-HT(1A) receptor occupancy in the monkey brainL Farde, B Andrée, N Ginovart, et al.
Psychopharmacology|January 1, 1993
5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidoneS Nyberg, L Farde, L Eriksson, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 18, 1998
Comparison of the transient equilibrium and continuous infusion method for quantitative PET analysis of [11C]raclopride bindingH Ito, J Hietala, G Blomqvist, et al.
The American Journal of Psychiatry|June 9, 1999
Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patientsS Nyberg, B Eriksson, G Oxenstierna, et al.
Pageof 41